Drug treatment in an ageing population: practical implications

Area of Science:

• Gerontology
• Pharmacology
• Public Health

Background:

• The global population is aging, with significant increases in individuals over 65 and 80 years old.
• Older adults receive a disproportionate share of prescription drugs, accounting for 45% of UK prescriptions.
• Age-related chronic diseases and prophylactic prescribing contribute to high medication use in the elderly.

Purpose of the Study:

• To highlight the importance of appropriate medication management in the elderly population.
• To emphasize the need for prescribers to understand age-related pharmacological issues.
• To address the balance between the benefits of prophylactic treatment and the risks of adverse drug effects in older patients.

Main Methods:

• Review of demographic trends in industrialized nations.
• Analysis of prescription data for older adults.
• Discussion of age-related pharmacological considerations.

Main Results:

• Older adults represent a growing percentage of the population and consume a large proportion of medications.
• Prophylactic treatments may offer greater benefits to older individuals due to higher disease risk.
• Increased drug use in the elderly elevates the risk of adverse drug events.

Conclusions:

• Prescribers require enhanced knowledge of geriatric pharmacology to make informed prescribing decisions.
• Balancing the benefits of necessary medications with potential risks is crucial for elderly patient care.
• Ensuring older adults are not denied beneficial treatments while minimizing harm is a key challenge.